APGE - CIK 0001974640
The table below shows Apogee Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $451.80M | $107.91M | $124.19M | $106.92M | $118.78M | $307.30M |
| Short-term investments | $608.09M | $419.38M | $381.23M | $406.41M | $407.27M | $368.93M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.07B |
| $540.10M |
| $516.12M |
| $521.53M |
| $534.48M |
| $681.85M |
| Property, plant & equipment | $5.28M | $6.03M | $6.44M | $5.68M | $1.42M | $714.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.29B | $626.16M | $657.77M | $714.16M | $776.29M | $800.66M |
| Accounts payable | $1.24M | $376.00K | $5.68M | $2.44M | $2.22M | $5.53M |
| Total current liabilities | $32.95M | $34.05M | $31.55M | $32.96M | $32.61M | $24.62M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $37.86M | $39.82M | $38.37M | $40.80M | $41.88M | $27.02M |
| Retained earnings | -$635.87M | -$492.37M | -$427.35M | -$361.25M | -$238.70M | -$189.68M |
| Total equity | - | - | - | - | - | - |